Ronghan Liu

5PUBLICATIONS
10CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsEpigenetics (incl. genome methylation and epigenomics)Physiotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 21, 2025
Fexofenadine protects against osteoarthritis by targeting Smad2 and STAT1 to enhance anabolism and binding cPLA2 to inhibit catabolism.

Kaiwen Liu, Xiaodi Zhang, Bin Ning

|Jul 05, 2025
Exosomal Gene Biomarkers in Osteosarcoma: Mifepristone as a Targeted Therapeutic Revealed by Multi-Omics Analysis.

Zheng Li, Jie Guo, Shaopeng Zhu

|Apr 19, 2025
IMPDH2's Central Role in Cellular Growth and Diseases: A Potential Therapeutic Target.

Zheng Li, Yunpeng Zou, Jiayao Niu

|Mar 13, 2023
Higenamine Promotes Osteogenesis Via IQGAP1/SMAD4 Signaling Pathway and Prevents Age- and Estrogen-Dependent Bone Loss in Mice.

Hui Dong, Ronghan Liu, Ke Zou

|Jan 30, 2019
Clinical Application of Teriparatide in Fracture Prevention: A Systematic Review.

Yuehong Chen, Ronghan Liu, Aubryanna Hettinghouse

Pageof 1

Frequent Collaborators

1 joint publications

Yuehong Chen

1 joint publications

Aubryanna Hettinghouse

1 joint publications

Shuya Wang

1 joint publications

Gang Liu